Question 1

Will it grow back?

Accepted Answer

For most people in the published literature, it appears to. What is described is telogen effluvium, a non-scarring shed in which metabolic stress tips far more follicles than usual out of active growth and into rest, and those hairs let go a few months afterward. Its defining feature is that it self-limits once the trigger settles. Two 2025 reviews of GLP-1 hair loss point the same way: telogen effluvium and ordinary pattern hair loss were the forms most often described, and more than 1,000 spontaneous adverse-event reports have not shown that the loss is permanent, though the reviews note that resolution was rarely tracked. Regrowth usually starts six to nine months after the shed begins, with most people seeing visible recovery by a year once weight loss slows. Scarring forms, the kind that destroy follicles, have appeared only rarely in these reports, and no causal link to the drugs has been shown. Shedding past nine to twelve months, or patchy bald spots rather than diffuse thinning, is a different diagnosis and needs a dermatologist.

Question 2

Is it the drug, or the weight loss?

Accepted Answer

Mostly the weight loss, with the drug responsible only for causing it. The cleanest evidence is what happens without any drug at all. Bariatric surgery produces similar rapid loss and is a well-documented trigger for the same shed, starting around two to three months after the operation. In the pooled STEP trials behind the Wegovy label, hair loss was reported by 3.3% on semaglutide 2.4 mg against 1% on placebo, and in STEP-1 the average person lost 14.9% of their body weight. Adverse-event reporting shows raised alopecia signals for both semaglutide and tirzepatide, but that method cannot separate a drug acting directly from a drug acting through the weight it removes. A 2025 review also noted most reported cases were never confirmed by a dermatologist. The practical consequence is that faster loss means more shedding, whichever molecule produced it, so the rate is the lever, not the brand.

Question 3

When does it start, and when does it stop?

Accepted Answer

The clock is predictable, which is reassuring once you know it. Telogen effluvium begins two to four months after its trigger, because hairs pushed into the resting phase take roughly 100 days to fall. On a GLP-1 that puts onset around month three to five for anyone losing quickly. The shed usually peaks around month four to six, then tapers as your weight and intake stabilize. Most people describe three to six months of active shedding, with regrowth visible six to nine months from when it started. The 2025 reviews add that how long the shed lasts on these drugs has not yet been tracked directly. So the threshold for escalating is clear. Past nine to twelve months, or with bald patches instead of general thinning, the differential widens to chronic telogen effluvium, pattern loss, alopecia areata or a nutritional deficiency. That needs a workup, not more waiting.

Question 4

Does biotin help?

Accepted Answer

Almost certainly not, unless you are biotin-deficient, and few people are. When researchers pooled every published case of biotin helping hair or nails, they found eighteen reports, each one in a patient with an underlying condition behind the poor growth, and concluded there was not enough there to recommend it to healthy adults. There is also a real downside people are not told about. High-dose biotin, at thousands of micrograms against a daily adequate intake of about 30, interferes with thyroid tests, troponin assays and other immunoassays used in emergency rooms. The FDA has issued safety communications about exactly this. It seems to work anyway because of timing. People typically start biotin at month four to six, precisely when telogen effluvium resolves on its own, and the supplement gets credit for the calendar. What does have evidence is enough protein, correcting low iron, and time.

Question 5

Is it worth getting my iron checked?

Accepted Answer

Yes. This is one of the few high-yield tests here, because low iron both causes this kind of shedding and is fixable. Running short of iron is a known cause of telogen effluvium, and ferritin belongs in any workup for shedding that will not settle. Note the threshold difference that catches people out: dermatology commonly wants ferritin above 30-50 ng/mL for hair-loss patients, well above the 15 ng/mL cutoff used to diagnose iron-deficiency anemia. A result your lab calls normal may still be too low for your hair. GLP-1 patients are unusually exposed here, because eating far less while dropping weight quickly can empty iron stores faster than meals refill them. Thyroid, vitamin D, zinc and B12 are the other labs commonly run. Do not supplement iron speculatively without a low ferritin, because excess iron carries its own risks.

Question 6

Will more protein stop it?

Accepted Answer

It will not stop a shed already underway, but too little protein will make one worse and longer. Follicles are protein-hungry structures, and low intake independently triggers this kind of shedding. The specific trap is that a smaller appetite and a slower stomach quietly drag daily protein under what muscle and hair both need, and it bites hardest during dose escalation, exactly when weight is coming off fastest. For scale, in STEP-1 lean tissue accounted for roughly 39% of total weight lost. Aim for roughly 1.2 to 1.6 grams for every kilogram you weigh, each day, split over three or four meals and eaten first when appetite is low. Protein cannot outrun the follicle cycle, and regrowth still takes months, but it removes a headwind you control.

Question 7

What about collagen powder?

Accepted Answer

No evidence for it, and the proposed mechanism does not hold up. Hair is made largely of keratin, not collagen, so collagen as a hair building block is biologically weak from the start. Neither 2025 review of GLP-1 hair loss identified any trial of collagen, or of any other supplement, for this shedding. What collagen powder does deliver is protein, roughly 10-20 grams a scoop, which counts toward the 1.2-1.6 g/kg target that does matter. So its use is as an expensive protein source wearing a hair-growth label. Whey isolate or cottage cheese gets you more complete protein for less. If you like it and it helps you hit your protein, carry on. Expecting it to specifically prevent or reverse the shed is not supported.

Question 8

Would losing weight more slowly help?

Accepted Answer

Probably, though no trial has tested fast against slow escalation for hair outcomes specifically, so this is reasoning from mechanism rather than from a result. The logic is sound. This kind of shedding scales with the size and speed of the stress behind it, and dermatology has long counted quick weight loss among those stresses. The extreme case supports it: bariatric surgery, at the far end of how fast weight can come off, causes it often enough that researchers proposed a dedicated name for the phenomenon. The Wegovy label says hair loss in its trials was associated with weight reduction, and it was reported more often on the 7.2 mg dose than on 2.4 mg (5.8% against 3.3%). So the lever exists. Holding a dose an extra month or two before stepping up, or maintaining below the maximum, slows the rate enough to plausibly reduce shedding. It also reduces total weight lost. That trade-off is one to settle with your prescriber rather than decide alone either way.

Question 9

Should I just stop the drug?

Accepted Answer

It is one option, and rarely the best one, partly because stopping can make the problem worse. The form the 2025 reviews describe most often, telogen effluvium, is a transient shed that usually settles once weight loss slows. Stopping abruptly tends to bring the weight back, and weight cycling is itself a metabolic stress that can set off further shedding. You can end up with the regain and the hair loss. The middle-ground moves clinicians use are to stretch the interval between dose increases, hold at a lower maintenance dose instead of climbing to maximum, fix protein, check ferritin, and reassess at six months. The adverse-event signal is real but reflects spontaneous reporting shaped by how much attention this side effect has had, so it is not evidence of permanent harm. Patchy, scarring or still-progressing shedding past a year is the exception, and that goes to dermatology rather than into a dose decision.

Question 10

Is it worse on tirzepatide than semaglutide?

Accepted Answer

No clear difference between the molecules, and the apparent one has a simpler explanation. Adverse-event analysis found raised alopecia reporting for both drugs against comparators, with broadly similar magnitude, and a separate four-database analysis found these drugs the most reported class for hair loss, though without meeting the formal threshold for a safety signal. What plausibly drives any impression that tirzepatide is worse is how much more weight it takes off: SURMOUNT-1 averaged about 20.9% at the top dose against STEP-1's 14.9%. More loss, faster, means more shedding, regardless of which drug produced it. No study in the 2025 reviews compared the two drugs at matched amounts of weight loss, so this is inference rather than a tested result. Still, switching molecules to protect your hair probably treats the wrong variable. The rate of loss is the thing you can change.

GLP-1 Hair Loss: 10 Questions, and What the Evidence Supports

Q1.Will it grow back?

Q2.Is it the drug, or the weight loss?

Q3.When does it start, and when does it stop?

Q4.Does biotin help?

Q5.Is it worth getting my iron checked?

Q6.Will more protein stop it?

Q7.What about collagen powder?

Q8.Would losing weight more slowly help?

Q9.Should I just stop the drug?

Q10.Is it worse on tirzepatide than semaglutide?

References

Questions and answers